FormuRx Pharmaceuticals
Delivering innovative medicine with FormuRx's exceptional R&D team and special formulations lipid-based drug delivery system, since 2019
Corporate philosophy
Goal-oriented drug design and development
予宇生技團隊於研發藥品領域中耕耘幾十年來的經驗，觀察到新創或小型生技製藥公司為加速獲利或爭取臨床試驗所需要之資金，常在早期階段忽略或簡化藥物製劑開發的需求，例如未能及早評估藥物的物化特性、材料選用的合規性與安全性、臨床給藥途徑及後續所影響的療效，甚至成品的可量產製造性等環環相扣的各種難題而導致臨床試驗過程不順利，進而阻礙產品的商業化發展，導致投資上的巨大損失。這一切如能在初期進行臨床前試驗時就能夠加以正視製劑精準優化之問題，就能大幅避免後續因製劑處方問題而導致龐大損失，於此，予宇以<以終為始>作為企業核心理念，並將藥物遞送系統的技術溢注在現今精準治療中，精準優化生技醫藥產業價值鏈的精準治療，涵蓋以下幾點，以提升藥物的價值。
- Developing drug delivery systems that cater to clinical needs
- Creating high technology threshold dosage form
- Integration of patented layouts
- Use of materials with regulatory approval for formulation composition
- Process design that can be scaled up for future clinical production
Core Technology
LBDDS (Lipid-based Drug Delivery System)
The FormuRx team possesses extensive experience in the design of lipid-based drug delivery systems, with a deep understanding of evaluating pharmaceutical raw materials, excipients, process efficiency, and parameters related to drug delivery systems. Leveraging the aforementioned expertise, FormuRx focuses on the following four lipid-based drug delivery system.
Future Development
Continuously developing technology platforms related to
Lipid-based drug delivery system
(LBDDS)
Developing
highly effective drugs
with low side effects
Forge partnerships with domestic
and international pharmaceutical
companies
Providing contract development services
for LBDDS-related
technologies
Phone
+886-2-2367-6828
service@formurx.com
Location
Rm. B406, No. 18, Siyuan St., Zhongzheng Dist., Taipei City 100,Taiwan(R.O.C.)